These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7563913)

  • 1. [Liver histology as a predictor of the response to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):975-80. PubMed ID: 7563913
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HCV genotype as a predictor of response to IFN therapy in chronic hepatitis C].
    Ebata M; Fukuda Y; Koyama Y; Hayakawa T; Kumada T; Nakano S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):954-8. PubMed ID: 7563909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term prognosis of the interferon-treated patients with chronic hepatitis C].
    Yoshida H; Iwabuchi S; Murayama M; Uchikoshi T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):675-9. PubMed ID: 7563855
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term follow up of histological changes in IFN-treated patients with chronic hepatitis C].
    Tsubota A
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):680-4. PubMed ID: 7563856
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C: ribavirin and/or interferon?
    Heathcote J
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S71-5. PubMed ID: 8986103
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon therapy in chronic viral hepatitis.
    Guptan RC; Sarin SK
    J Assoc Physicians India; 1995; Suppl 3():44-51. PubMed ID: 8773122
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibility and significance of interferon therapy for liver cirrhosis type C].
    Iwabuchi S; Osada T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):746-53. PubMed ID: 7563868
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C.
    Nelson DR; Davis GL
    Compr Ther; 1997 Apr; 23(4):269-76. PubMed ID: 9167919
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic viral hepatitis: when interferon does not work].
    Costa C; Rizzetto M
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):127-31. PubMed ID: 7542484
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy].
    Hino K; Murakami C; Fujii K; Okazaki M; Okuda M; Hanada H; Okita K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):949-53. PubMed ID: 7563907
    [No Abstract]   [Full Text] [Related]  

  • 16. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Criteria of IFN treatment for chronic hepatitis C].
    Yano M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):986-90. PubMed ID: 7563915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.